These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9337155)

  • 1. Molecular epidemiology of atherosclerosis.
    De Flora S; Izzotti A; Walsh D; Degan P; Petrilli GL; Lewtas J
    FASEB J; 1997 Oct; 11(12):1021-31. PubMed ID: 9337155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer biomarkers in human atherosclerotic lesions: detection of DNA adducts.
    Izzotti A; De Flora S; Petrilli GL; Gallagher J; Rojas M; Alexandrov K; Bartsch H; Lewtas J
    Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):105-10. PubMed ID: 7742716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprevention of carcinogen-DNA adducts and chronic degenerative diseases.
    Izzotti A; D'Agostini F; Bagnasco M; Scatolini L; Rovida A; Balansky RM; Cesarone CF; De Flora S
    Cancer Res; 1994 Apr; 54(7 Suppl):1994s-1998s. PubMed ID: 8137327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA adducts and chronic degenerative disease. Pathogenetic relevance and implications in preventive medicine.
    De Flora S; Izzotti A; Randerath K; Randerath E; Bartsch H; Nair J; Balansky R; van Schooten F; Degan P; Fronza G; Walsh D; Lewtas J
    Mutat Res; 1996 Dec; 366(3):197-238. PubMed ID: 9033668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid peroxidation-derived etheno-DNA adducts in human atherosclerotic lesions.
    Nair J; De Flora S; Izzotti A; Bartsch H
    Mutat Res; 2007 Aug; 621(1-2):95-105. PubMed ID: 17412369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adducts to nuclear DNA and mitochondrial DNA as biomarkers in chemoprevention.
    De Flora S; Balansky R; Scatolini L; Di Marco C; Gasparini L; Orlando M; Izzotti A
    IARC Sci Publ; 1996; (139):291-301. PubMed ID: 8923039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased DNA alterations in atherosclerotic lesions of individuals lacking the GSTM1 genotype.
    Izzotti A; Cartiglia C; Lewtas J; De Flora S
    FASEB J; 2001 Mar; 15(3):752-7. PubMed ID: 11259393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of N-(deoxyguanosin-8-yl)-4-azobiphenyl by (32)P-postlabeling analyses of DNA in human uroepithelial cells exposed to proximate metabolites of the environmental carcinogen 4-aminobiphenyl.
    Hatcher JF; Swaminathan S
    Environ Mol Mutagen; 2002; 39(4):314-22. PubMed ID: 12112383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione depletion enhances the formation of endogenous cyclic DNA adducts derived from t-4-hydroxy-2-nonenal in rat liver.
    Chung FL; Komninou D; Zhang L; Nath R; Pan J; Amin S; Richie J
    Chem Res Toxicol; 2005 Jan; 18(1):24-7. PubMed ID: 15651845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of DNA adducts, DNA and RNA oxidative lesions, and 3-hydroxybenzo(a)pyrene as biomarkers of DNA damage in lung following intravenous injection of the parent compound in rats.
    Marie-Desvergne C; Maître A; Bouchard M; Ravanat JL; Viau C
    Chem Res Toxicol; 2010 Jul; 23(7):1207-14. PubMed ID: 20593881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined micropreparative techniques with synchronous fluorescence spectroscopy or 32P-postlabelling assay for carcinogen-DNA adduct determination.
    Shields PG; Kato S; Bowman ED; Petruzzelli S; Cooper DP; Povey AC; Weston A
    IARC Sci Publ; 1993; (124):243-54. PubMed ID: 8225491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA adducts and human atherosclerotic lesions.
    Binková B; Strejc P; Boubelík O; Stávková Z; Chvátalová I; Srám RJ
    Int J Hyg Environ Health; 2001 Oct; 204(1):49-54. PubMed ID: 11725345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the DNA damaging potential of cannabis cigarette smoke by the determination of acetaldehyde derived N2-ethyl-2'-deoxyguanosine adducts.
    Singh R; Sandhu J; Kaur B; Juren T; Steward WP; Segerbäck D; Farmer PB
    Chem Res Toxicol; 2009 Jun; 22(6):1181-8. PubMed ID: 19449825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, characterization, and 32P-postlabeling of N-(deoxyguanosin)-4-aminobiphenyl 3'-phosphate adducts.
    Haack T; Boche G; Kliem C; Wiessler M; Albert D; Schmeiser HH
    Chem Res Toxicol; 2004 Jun; 17(6):776-84. PubMed ID: 15206898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (E)-2-hexenal-induced DNA damage and formation of cyclic 1,N2-(1,3-propano)-2'-deoxyguanosine adducts in mammalian cells.
    Gölzer P; Janzowski C; Pool-Zobel BL; Eisenbrand G
    Chem Res Toxicol; 1996; 9(7):1207-13. PubMed ID: 8902278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of 1, N2-propanodeoxyguanosine adducts as potential endogenous DNA lesions in rodent and human tissues.
    Nath RG; Ocando JE; Chung FL
    Cancer Res; 1996 Feb; 56(3):452-6. PubMed ID: 8564951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term moderate exercise programs reduce oxidative DNA damage as determined by high-performance liquid chromatography-electrospray ionization-mass spectrometry in patients with colorectal carcinoma following primary treatment.
    Allgayer H; Owen RW; Nair J; Spiegelhalder B; Streit J; Reichel C; Bartsch H
    Scand J Gastroenterol; 2008 Aug; 43(8):971-8. PubMed ID: 18609189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid peroxidation-induced DNA damage in cancer-prone inflammatory diseases: a review of published adduct types and levels in humans.
    Nair U; Bartsch H; Nair J
    Free Radic Biol Med; 2007 Oct; 43(8):1109-20. PubMed ID: 17854706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of 1,N2-propanodeoxyguanosine adducts as endogenous DNA lesions in rodents and humans.
    Chung FL; Zhang L; Ocando JE; Nath RG
    IARC Sci Publ; 1999; (150):45-54. PubMed ID: 10626207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A solid-phase extraction/high-performance liquid chromatography-based (32)P-postlabeling method for detection of cyclic 1,N(2)-propanodeoxyguanosine adducts derived from enals.
    Pan J; Davis W; Trushin N; Amin S; Nath RG; Salem N; Chung FL
    Anal Biochem; 2006 Jan; 348(1):15-23. PubMed ID: 16289438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.